SCHEMBL8398530

SCHEMBL8398530

CCOC(=O)c1cnc(-c2ccccc2)nc1NN

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.71
SMN1; SMN2 Q16637 3/20 0.71
MAPT P10636 2/20 0.71
NPC1 O15118 2/20 0.71
RAB9A P51151 2/20 0.71
TP53 P04637 1/20 0.71
LMNA P02545 4/20 0.69
MAPK1 P28482 1/20 0.69
ATM Q13315 1/20 0.69
FOS P01100 6/20 0.64
JUN P05412 6/20 0.64
NFKB1 P19838 6/20 0.64
NFKB2 Q00653 6/20 0.64
RELA Q04206 6/20 0.64
CYP1A2 P05177 4/20 0.63
POLB P06746 2/20 0.63
CYP2C9 P11712 2/20 0.63
CYP2C19 P33261 2/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
CSNK1D P48730 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5914410 0.89 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL11158474 0.88 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL11160276 0.86 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL7210795 0.85 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL7210767 0.85 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL8394846 0.85 FOS (0.67) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL12929684 0.84 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL11164512 0.84 NPSR1 (0.67) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL11285512 0.84 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL11160403 0.83 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935966-A COMPOUNDS THAT BLOCK THE ACTIVATION OF TRANSCRIPTION FACTORS THROUGH INHIBITION OF A FAMILY OF SPECIFIC KINASES, DECREASING PROINFLAMMATORY PROTEINS TO TREAT AUTOIMMUNE DISEASES AND AS GENERAL ANTIINFLAMMATORY AGENTS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-10 US disclosed
WO-1998038171-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-03 WO disclosed
WO-1997009325-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1997-03-13 WO disclosed